vs
Commerce.com, Inc.（CMRC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Commerce.com, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$89.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -9.3%，领先393.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 2.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.5%）
SPS Commerce是一家总部位于美国明尼苏达州明尼阿波利斯市的科技企业，核心业务是为客户提供基于云端的供应链管理软件解决方案。公司除在美国本土设有分支机构外，还在阿姆斯特丹、北京、香港、多伦多、悉尼等全球多个城市布局了办公网点。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CMRC vs RIGL — 直观对比
营收规模更大
CMRC
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出18.3%
2.9%
净利率更高
RIGL
高出393.4%
-9.3%
两年增速更快
RIGL
近两年复合增速
5.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.5M | $69.8M |
| 净利润 | $-8.4M | $268.1M |
| 毛利率 | 78.3% | 91.5% |
| 营业利润率 | -7.4% | 33.2% |
| 净利率 | -9.3% | 384.0% |
| 营收同比 | 2.9% | 21.2% |
| 净利润同比 | -250.0% | 1769.2% |
| 每股收益（稀释后） | $-0.11 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMRCRIGL
| Q4 25 | $89.5M | $69.8M | ||
| Q3 25 | $86.0M | $69.5M | ||
| Q2 25 | $84.4M | $101.7M | ||
| Q1 25 | $82.4M | $53.3M | ||
| Q4 24 | $87.0M | $57.6M | ||
| Q3 24 | $83.7M | $55.3M | ||
| Q2 24 | $81.8M | $36.8M | ||
| Q1 24 | $80.4M | $29.5M |
净利润CMRCRIGL
| Q4 25 | $-8.4M | $268.1M | ||
| Q3 25 | $-2.2M | $27.9M | ||
| Q2 25 | $-8.4M | $59.6M | ||
| Q1 25 | $-353.0K | $11.4M | ||
| Q4 24 | $-2.4M | $14.3M | ||
| Q3 24 | $-7.0M | $12.4M | ||
| Q2 24 | $-11.3M | $-1.0M | ||
| Q1 24 | $-6.4M | $-8.2M |
毛利率CMRCRIGL
| Q4 25 | 78.3% | 91.5% | ||
| Q3 25 | 78.4% | 93.2% | ||
| Q2 25 | 79.0% | 95.6% | ||
| Q1 25 | 79.4% | 91.7% | ||
| Q4 24 | 77.6% | 89.9% | ||
| Q3 24 | 76.3% | 85.5% | ||
| Q2 24 | 75.8% | 92.4% | ||
| Q1 24 | 77.1% | 93.1% |
营业利润率CMRCRIGL
| Q4 25 | -7.4% | 33.2% | ||
| Q3 25 | -0.5% | 40.9% | ||
| Q2 25 | -8.0% | 60.1% | ||
| Q1 25 | -2.9% | 23.9% | ||
| Q4 24 | -0.9% | 28.9% | ||
| Q3 24 | -23.0% | 25.4% | ||
| Q2 24 | -16.5% | 1.2% | ||
| Q1 24 | -10.2% | -23.6% |
净利率CMRCRIGL
| Q4 25 | -9.3% | 384.0% | ||
| Q3 25 | -2.6% | 40.2% | ||
| Q2 25 | -9.9% | 58.6% | ||
| Q1 25 | -0.4% | 21.5% | ||
| Q4 24 | -2.7% | 24.9% | ||
| Q3 24 | -8.4% | 22.5% | ||
| Q2 24 | -13.8% | -2.8% | ||
| Q1 24 | -8.0% | -27.9% |
每股收益（稀释后）CMRCRIGL
| Q4 25 | $-0.11 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.10 | $3.28 | ||
| Q1 25 | $0.00 | $0.63 | ||
| Q4 24 | $-0.03 | $0.82 | ||
| Q3 24 | $-0.09 | $0.70 | ||
| Q2 24 | $-0.15 | $-0.06 | ||
| Q1 24 | $-0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $155.0M |
| 总债务越低越好 | $157.0M | $52.5M |
| 股东权益账面价值 | $39.4M | $391.5M |
| 总资产 | $308.8M | $513.6M |
| 负债/权益比越低杠杆越低 | 3.99× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CMRCRIGL
| Q4 25 | $141.1M | $155.0M | ||
| Q3 25 | $142.0M | $137.1M | ||
| Q2 25 | $134.5M | $108.4M | ||
| Q1 25 | $120.7M | $77.1M | ||
| Q4 24 | $178.2M | $77.3M | ||
| Q3 24 | $168.4M | $61.1M | ||
| Q2 24 | $275.8M | $49.1M | ||
| Q1 24 | $265.2M | $49.5M |
总债务CMRCRIGL
| Q4 25 | $157.0M | $52.5M | ||
| Q3 25 | $157.3M | $60.0M | ||
| Q2 25 | $157.5M | $60.0M | ||
| Q1 25 | $157.8M | $60.0M | ||
| Q4 24 | $216.5M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $340.9M | $60.0M | ||
| Q1 24 | $340.5M | $60.0M |
股东权益CMRCRIGL
| Q4 25 | $39.4M | $391.5M | ||
| Q3 25 | $42.8M | $117.6M | ||
| Q2 25 | $38.8M | $81.9M | ||
| Q1 25 | $38.1M | $18.6M | ||
| Q4 24 | $33.4M | $3.3M | ||
| Q3 24 | $29.0M | $-14.6M | ||
| Q2 24 | $26.1M | $-29.9M | ||
| Q1 24 | $26.9M | $-31.7M |
总资产CMRCRIGL
| Q4 25 | $308.8M | $513.6M | ||
| Q3 25 | $309.5M | $242.5M | ||
| Q2 25 | $302.5M | $206.7M | ||
| Q1 25 | $286.3M | $176.0M | ||
| Q4 24 | $340.3M | $164.0M | ||
| Q3 24 | $335.1M | $139.4M | ||
| Q2 24 | $452.5M | $128.4M | ||
| Q1 24 | $442.5M | $126.5M |
负债/权益比CMRCRIGL
| Q4 25 | 3.99× | 0.13× | ||
| Q3 25 | 3.67× | 0.51× | ||
| Q2 25 | 4.06× | 0.73× | ||
| Q1 25 | 4.14× | 3.23× | ||
| Q4 24 | 6.49× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 13.06× | — | ||
| Q1 24 | 12.65× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $980.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.2M | — |
| 自由现金流率自由现金流/营收 | -2.4% | — |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $16.9M | — |
8季度趋势，按日历期对齐
经营现金流CMRCRIGL
| Q4 25 | $980.0K | $22.0M | ||
| Q3 25 | $10.6M | $24.0M | ||
| Q2 25 | $13.6M | $30.5M | ||
| Q1 25 | $401.0K | $-893.0K | ||
| Q4 24 | $12.4M | $14.5M | ||
| Q3 24 | $5.6M | $21.7M | ||
| Q2 24 | $11.7M | $302.0K | ||
| Q1 24 | $-3.4M | $-5.0M |
自由现金流CMRCRIGL
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | $-424.0K | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $-4.2M | — |
自由现金流率CMRCRIGL
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | -0.5% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | -5.3% | — |
资本支出强度CMRCRIGL
| Q4 25 | 3.5% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 1.0% | — |
现金转化率CMRCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
RIGL
暂无分部数据
